Humoral response to cancer as a tool for biomarker discovery - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Journal of Proteomics Année : 2009

Humoral response to cancer as a tool for biomarker discovery

Résumé

There is an important need to find relevant biomarkers that show high sensitivity and specificity for early diagnosis and prognosis of cancer. An immune response to cancer is elicited in humans, as demonstrated in part by the identification of autoantibodies against a number of tumor-associated antigens in sera from patients with different types of cancer. Identification of tumor-associated antigens and their cognate autoantibodies is a promising strategy for the discovery of relevant biomarkers. During the past few years, proteomic approaches, including SEREX, SERPA and, more recently, protein microarrays, have been the dominant strategies used to identify tumor-associated antigens and their cognate autoantibodies. In this review, we aim to describe advantages, drawbacks, and recent improvements of these approaches for the study of humoral responses.
Fichier non déposé

Dates et versions

hal-01936194 , version 1 (27-11-2018)

Identifiants

Citer

C. Desmetz, C. Cortijo, Alain Mangé, J. Solassol. Humoral response to cancer as a tool for biomarker discovery. Journal of Proteomics, 2009, 72 (6), pp.982 - 988. ⟨10.1016/j.jprot.2009.06.004⟩. ⟨hal-01936194⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More